Maxim Group Initiates Coverage On Rockwell Medical with Buy Rating, Announces Price Target of $5
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Anthony Vendetti has initiated coverage on Rockwell Medical (NASDAQ:RMTI) with a Buy rating and a price target of $5.
October 05, 2023 | 3:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rockwell Medical has been initiated with a Buy rating by Maxim Group, with a price target of $5.
The initiation of coverage by Maxim Group with a Buy rating and a price target of $5 indicates a positive outlook for Rockwell Medical. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100